On the other hand, in other categories where the product value proposition was perceived as higher (e.g. somatropin) and were more highly differentiated, the biosimilars were not able to achieve ...

† Dose injected directly into vein or running intravenous fluids. ‡ Intermittent intravenous infusion. § Aminoglycosides are not recommended for patients with renal insufficiency as less ...